Can Fite Biopharma Ltd ADR (CANF)

Can Fite Biopharma Ltd ADR (CANF) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $5.9M; returns 1 day -2.7%, 1 week +1.1%, 1 year -81.6%.

Can-Fite BioPharma Ltd. is an Israeli clinical-stage biopharmaceutical company focused on developing proprietary orally bioavailable small-molecule drugs that target the A3 adenosine receptor (A3AR) for the treatment of oncological, inflammatory, and metabolic diseases.

Groups CANF belongs to

• Biotechnology
• Recent Reverse Splits
• Israel Companies
• Israel
• Healthcare
• Biopharmaceutical
• Pharmaceuticals
• Clinical Stage Biopharma
• Clinical Stage
• Oncology
• Liver Disease
• Autoimmune Diseases
• Metabolic Disorders
• Chronic Inflammatory Diseases

CANF financial model: income statement, cash flow and balance sheet